Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
936.00    -12.00 (-1.27%)
Bid:
934.00
Ask:
942.00
Spread: 8.00 (0.857%)
Market Cap: £256.19m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Director/PDMR Shareholding

29 Feb 2024 07:00

RNS Number : 8678E
Gooch & Housego PLC
29 February 2024
 

29 February 2024

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Director/PDMR Shareholding

 

Gooch & Housego PLC (AIM:GHH), the specialist manufacturer of photonic components and systems announces that the Company was notified on 28 February 2024 that, on the same date, Gary Bullard, Chairman, purchased 377 Ordinary Shares at a price of £4.94 per share and that Elaine Sullivan, a person closely associated to Gary Bullard, purchased 263 Ordinary shares at a price of £4.94 per Ordinary Share.

 

Following these transactions, Gary Bullard has increased his interest to 43,721 Ordinary Shares in the Company representing 0.17% of the Company's total issued share capital.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

1. Gary Bullard

2. Elaine Sullivan

 

2

Reason for the notification

 

a)

Position/status

1. Chairman

2. Person Closely Associated to the Chairman Gary Bullard

 

b)

Initial notification/Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Gooch & Housego Plc

 

b)

LEI

213800DO3D00KYOPA952

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument.

Identification code

Ordinary shares of 20 pence each

GB0002259116

 

b)

Nature of transaction

 

Purchase of ordinary shares

 

 

 

c)

Price(s) and volume(s)

Price(s)

1. £4.94

2. £4.94

Volume(s)

1. 377

2. 263

 

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

 

e)

Date of the transaction

28 February 2024

 

f)

Place of the transaction

London Stock Exchange

 

 

 

For further information please contact:

 

Charlie Peppiatt, Chief Executive Officer

Chris Jewell, Chief Financial Officer 

Gooch & Housego PLC

+44 (0) 1460 256440

 

Mark Court / Sophie Wills/ George Cleary

G&H@buchanan.uk.com

Buchanan

+44 (0) 20 7466 5000

 

Christopher Baird / David Anderson

Investec Bank plc

+44 (0) 20 7597 5970

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDGGDDGBDDGSI
Date   Source Headline
8th Feb 202110:20 amRNSHolding(s) in Company
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
7th Jan 202112:17 pmRNSGrant of LTIP Awards
23rd Dec 20207:00 amRNSLaunch of Satellite Laser Communication System
18th Dec 20207:00 amRNSPosting of Annual Report and AGM Notice
1st Dec 20207:00 amRNSPreliminary Results
16th Nov 20207:00 amRNSNotification of Full Year Results
6th Oct 20207:00 amRNSFull Year Trading Update
2nd Sep 20207:00 amRNSTrading Update
1st Sep 202012:07 pmRNSSecond Price Monitoring Extn
1st Sep 202012:02 pmRNSPrice Monitoring Extension
3rd Jun 20202:53 pmRNSDirector/PDMR Shareholding
2nd Jun 202011:37 amRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSInterim Results
18th May 20207:00 amRNSNotification of Half Year Results
11th May 20207:00 amRNSAppointment of Non-Executive Director
23rd Apr 20204:23 pmRNSHolding(s) in Company
9th Apr 20203:25 pmRNSHolding(s) in Company
7th Apr 20207:00 amRNSHalf Year Trading Update
27th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSUS Facilities Update
17th Mar 20201:22 pmRNSFremont Facility Update
16th Mar 20201:56 pmRNSDirector/PDMR Shareholding
6th Mar 20209:45 amRNSDirector Share Purchase
3rd Mar 20207:00 amRNSStreamlining of Manufacturing
19th Feb 202012:23 pmRNSResult of AGM
19th Feb 20207:00 amRNSAGM Trading Update
3rd Feb 202012:08 pmRNSIssue of Equity and Total Voting Rights
14th Jan 202010:21 amRNSGrant of LTIP Awards
27th Dec 20193:26 pmRNSDirectorate: David Bauernfeind
11th Dec 20197:00 amRNSPosting of Annual Report and AGM Notice
9th Dec 20198:50 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSPreliminary Results
20th Nov 20198:42 amRNSBlock listing Interim Review
15th Nov 20194:41 pmRNSSecond Price Monitoring Extn
15th Nov 20194:35 pmRNSPrice Monitoring Extension
11th Nov 201911:18 amRNSConfirmation of Directorate Change
8th Nov 201912:54 pmRNSTotal Voting Rights
7th Oct 20197:00 amRNSFull Year Trading Update and Results Notification
6th Aug 201912:02 pmRNSPrice Monitoring Extension
18th Jul 201910:11 amRNSChief Financial Officer Appointment Timing Update
1st Jul 201910:57 amRNSDirector/PDMR Shareholding
6th Jun 201912:58 pmRNSDirector Share Purchase
4th Jun 20194:23 pmRNSDirectors' Share Purchases
4th Jun 20197:00 amRNSDirectorate Change
4th Jun 20197:00 amRNSInterim Results
28th May 20199:52 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.